Back to results
UnknownPhase 1Phase 2

A Study of SHR-A1811 Combined With Capecitabine in Treatment of Unresectable or Metastatic Breast Cancer With Low HER2 Expression.

NCT05845138

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

The Second Hospital of Anhui Medical University

Hefei, Anhui, China

+8 additional locations

View on ClinicalTrials.gov